KAPAKairos Pharma, LTD. · NYSE American · $0.87 · $3.24M mkt cap
Assessed Sep 1, 2026 · Reassessment
Is the float you're seeing correct?
2.46M
Estimated float

Post-split shares outstanding (23,697,683 / 7 = 3,385,383) less implied affiliate holdings carried forward from the January 2026 public-float disclosure (6,826,666 / 7 = 975,238).

Confirmed · within 9%
2.25M
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener's float is right for KAPA. Trade off 2.46M shares. What it does not show you is what is about to be added to it.

Dilution risk7/10HIGH
CONFIDENCE: MEDIUM

The float your screener shows is right, at 2.46M. An active $3.2M ATM, 1 floorless convertible note and 2 reverse splits can add another 29% of the float.

  • Variable-rate equity line with capacity many multiples of float. The Helena Global ELOC retains approximately $26.8M of its $30M capacity against a post-split float worth roughly $4.1M — a 6.5x ratio.

  • Rapid share count growth via active ATM issuance. Shares outstanding grew 10.7% in a single quarter — from 21,411,198 on 2026-05-11 to 23,697,683 on 2026-08-12 (XBRL-deterministic).

  • Reverse split executed today — dilution-cycle reset. A 1-for-7 reverse split took effect at the start of trading on 2026-09-01, the second reverse split in three years (following 1-for-2.5 on 2023-05-10).

From today's float to the ceiling

shares
2.46M
Estimated float
tradeable today
+0 can sell now
2.46M
Effective supply
float plus what sells on notice
+1.64M if floors are cut and warrants exercise
4.11M
Fully diluted
ceiling

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
2.46M
Can sell now
Warrants in the money
None of the outstanding warrants are exercisable at this price.
+0
Effective supply
2.46M
Converts only if floors are cut
Notes with no conversion price set
Sized in dollars until a price or floor is set; not counted in the ceiling.
$26.80M
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+611.6K
Other, per engine ceiling
Included in the engine's fully-diluted count but not itemised in the filings we parsed.
+1.03M
Fully diluted
4.11M

ATM program active with $3.2M of registered capacity remaining. Public float is under $75M, so the baby-shelf rule caps primary sales near $652K per 12 months; the headline figure is not the near-term supply.

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
$0.87
Market cap
$3.24M
Shares outstanding
3.39M
Reported float
2.25M
Avg volume
1.69M
Reverse splits
2 · latest 1-for-7 · Sep 1, 2026
Going concern
Yes · 2.6 quarters runway
Quarterly burn
$1.02M

Market data as of Oct 8, 2026

Key dates

  • Nov 14, 2026 · Q3 2026 10-Q due — will disclose ATM/ELOC issuance for the quarter and the first post-split share count.
  • Jan 1, 2027 · 2023 Equity Incentive Plan evergreen provision automatically adds 5% of shares outstanding at 2026-12-31 to the reserve; repeats every January 1 through 2033.
  • Dec 1, 2027 · Helena ELOC termination date (36-month anniversary), or earlier upon full $30,000,000 purchase.
  • Jan 23, 2029 · Form S-3 shelf (333-292686) three-year expiry.
KAPA Float & Dilution Analysis | ShareStructure.io